Title
Category
Credits
Event date
Cost
  • Research to Practice
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Daniel Richardson, MD, MA, MSc, will explore best practices to approach the care of older adults with leukemia. He will also discuss novel therapeutic options for patients with acute lymphoblastic and acute myeloid leukemia alongside practical considerations to approach shared decision-making.
  • Southeastern American Indian Cancer Health Equity Partnership
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation
$0.00
Embracing Indigenous Wisdom in Evidence Based Cancer Prevention: A Path of Collaboration, Respect, and Insight on Duke’s Voyage” is a presentation that explores the partnership between modern scientific research and indigenous wisdom in the pursuit of effective cancer prevention strategies. It underscores the humility in learning from indigenous knowledge, and the discovery of insights that can enhance evidence-based approaches to cancer prevention.
  • Southeastern American Indian Cancer Health Equity Partnership
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
In working to address Native American cancer health disparities, it is imperative to build partnerships with tribal communities to increase their trust in the potential benefits of cancer research efforts. The Partnership for Native American Cancer Prevention was established in 2002 and the Partnership’s approach is to expand capacity for culturally-sensitive and community-relevant research on cancer and to continue to develop respectful collaborations that empower sovereign Native American communities to define, implement, and achieve their goals for cancer health equity.
  • Advanced Practice Provider
  • 1.00 Participation
$0.00
Cancer touches all of our lives. For many Native communities, fears of cancer risk from environmental sources beyond their control are common. Some researchers, usually unaware of Native community concerns, can harbor the perspective that Native communities could be fruitful populations for studying the genetic risks of cancer. This webinar will help both sides of this chasm understand the other's point of view, hopefully leading to more effective communications and priority setting.
  • Southeastern American Indian Cancer Health Equity Partnership
  • 1.00 Participation
$0.00
Donald Warne, MD, MPH, will describe health disparities and inequities related to American Indian cancer control. We will explore the legal basis for federally-funded health services to American Indians and the complexity of health policy at the federal, state and tribal levels that impact cancer control. We will provide a framework for health equity and a path forward to improve outcomes.
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Introduction and discussion of supportive care programs in a "home away from home" for patients during their cancer journey.
  • Research to Practice
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 AMA PRA Category 1 Credit
  • 1.50 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Frances Collichio, MD, reviews the common and uncommon side effects of immune check point inhibitors. She also discusses the relatively new concept of delayed immune related events.
  • Research to Practice
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 AMA PRA Category 1 Credit
  • 1.25 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Dominique Higgins, MD, PhD, provides an overview of diagnostic criteria for primary CNS brain tumors, and the current approved and investigational treatments that are available and on the horizon.
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 AMA PRA Category 1 Credit
  • 1.50 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Jacob Stein, MD, MPH, reviews several of the most common medical emergencies that arise when caring for patients with cancer. We highlight key aspects of presentation, diagnosis and management, with pearls for clinicians along the way.
  • Advanced Practice Provider
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Patients undergoing treatment for cancer utilize many medications that have relevant drug-gene interactions. The use of pharmacogenomic testing can assist with drug selection, drug dosing, and the development of personalized medication monitoring plans. Amber Cipriani, PharmD, BCOP, will describe some common examples of drug-gene interactions relevant to oncology. She will also discuss current efforts to expand the use of pharmacogenomic testing into current clinical practice.

Pages